I expect any company which collates information about geospatial datasets to release the substance of them, yes. Maybe there's an IPR lockup window, but at some point the cadastral facts of the world are part of the commons to me.
I would think there's actually a lot of epidemiology data which also should be winding up in the public domain getting locked up in medical IPR. I could make the same case. Cochrane reports rely on being able to do meta analysis over existing datasets. Thats value.
I expect any company which collates information about geospatial datasets to release the substance of them, yes. Maybe there's an IPR lockup window, but at some point the cadastral facts of the world are part of the commons to me.
I would think there's actually a lot of epidemiology data which also should be winding up in the public domain getting locked up in medical IPR. I could make the same case. Cochrane reports rely on being able to do meta analysis over existing datasets. Thats value.